5BR7

Structure of UDP-galactopyranose mutase from Corynebacterium diphtheriae in complex with citrate ion

5BR7 の概要

• エントリーDOI: 10.2210/pdb5br7/pdb
• 分子名称: UDP-galactopyranose mutase, FLAVIN-ADENINE DINUCLEOTIDE, 1,2-ETHANEDIOL, ... (7 entities in total)
• 機能のキーワード: udp-galactopyranose mutase, corynebacterium diphtheriae, galactofuranose, galactopyranose, citrate, fad, sodium ion, isomerase
• 由来する生物種: Corynebacterium diphtheriae (strain ATCC 700971 / NCTC 13129 / Biotype gravis)
• タンパク質・核酸の鎖数: 1
• 化学式量合計: 47186.86

構造登録者

Wangkanont, K.,Kiessling, L.L.,Forest, K.T. (登録日: 2015-05-29, 公開日: 2016-06-01, 最終更新日: 2023-09-27)

主引用文献

Wangkanont, K.,Winton, V.J.,Forest, K.T.,Kiessling, L.L.
Conformational Control of UDP-Galactopyranose Mutase Inhibition.
Biochemistry, 56:3983-3992, 2017

PubMed Abstract: UDP-galactopyranose mutase (Glf or UGM) catalyzes the formation of uridine 5'-diphosphate-α-d-galactofuranose (UDP-Galf) from UDP-galactopyranose (UDP-Galp). The enzyme is required for the production of Galf-containing glycans. UGM is absent in mammals, but members of the Corynebacterineae suborder require UGM for cell envelope biosynthesis. The need for UGM in some pathogens has prompted the search for inhibitors that could serve as antibiotic leads. Optimizing inhibitor potency, however, has been challenging. The UGM from Klebsiella pneumoniae (KpUGM), which is not required for viability, is more effectively impeded by small-molecule inhibitors than are essential UGMs from species such as Mycobacterium tuberculosis or Corynebacterium diphtheriae. Why KpUGM is more susceptible to inhibition than other orthologs is not clear. One potential source of difference is UGM ortholog conformation. We previously determined a structure of CdUGM bound to a triazolothiadiazine inhibitor in the open form, but it was unclear whether the small-molecule inhibitor bound this form or to the closed form. By varying the terminal tag (CdUGM-His and GSG-CdUGM), we crystallized CdUGM to capture the enzyme in different conformations. These structures reveal a pocket in the active site that can be exploited to augment inhibitor affinity. Moreover, they suggest the inhibitor binds the open form of most prokaryotic UGMs but can bind the closed form of KpUGM. This model and the structures suggest strategies for optimizing inhibitor potency by exploiting UGM conformational flexibility.

PubMed: 28608671
DOI: 10.1021/acs.biochem.7b00189

実験手法

X-RAY DIFFRACTION (1.95 Å)